Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 355,000 $ 1,124,000
Prepaid expenses 50,000 50,000
Total current assets 405,000 1,174,000
Cash and investments held in trust account 306,566,000 307,338,000
Total assets 306,971,000 308,512,000
Current liabilities:    
Accounts payable 6,000 46,000
Accrued liabilities 4,834,000 2,119,000
Deferred compensation 220,000 116,000
Total current liabilities 5,060,000 2,281,000
Other liabilities:    
Deferred underwriting compensation 10,179,000 10,179,000
Total liabilities 15,239,000 12,460,000
Commitments and contingencies
Common stock subject to possible redemption; 28,389,295 and 28,817,019 shares at September 30, 2020 and December 31, 2019, respectively, (at value of approximately $10.10 per share) 286,732,000 291,052,000
Stockholders' equity:    
Preferred stock, $0.0001 par value; 1,000,000 authorized shares; none issued or outstanding at September 30, 2020 and December 31, 2019
Common stock value
Additional paid-in-capital 5,985,000 3,842,000
(Accumulated deficit) Retained earnings (986,000) 1,157,000
Total stockholders' equity 5,000,000 5,000,000
Total liabilities and stockholders' equity 306,971,000 308,512,000
Class A Common Stock    
Stockholders' equity:    
Common stock value
Class B Common Stock    
Stockholders' equity:    
Common stock value 1,000 1,000
Total stockholders' equity $ 1,000 $ 1,000